Seattle Genetics Inc (NASDAQ:SGEN)

54.48
Delayed Data
As of Feb 16
 -0.37 / -0.67%
Today’s Change
45.31
Today|||52-Week Range
71.32
+1.83%
Year-to-Date

Today’s Trading

Previous close54.85
Today’s open54.80
Day’s range54.27 - 55.81
Volume965,192
Average volume (3 months)1,147,308
Market cap$8.6B
Data as of 4:00pm ET, 02/16/2018

Growth & Valuation

Earnings growth (last year)+12.00%
Earnings growth (this year)--
Earnings growth (next 5 years)-28.70%
Revenue growth (last year)+15.33%
P/E ratioNM
Price/Sales15.88
Price/Book11.61

Competitors

 Today’s
change
Today’s
% change
TSROTESARO Inc-1.03-1.69%
ALKSAlkermes Plc+3.51+5.51%
ALNYAlnylam Pharmaceutic...+1.14+0.94%
IONSIonis Pharmaceutical...+0.27+0.54%
Data as of 4:00pm ET, 02/16/2018

Financials

Last reporting dateFebruary 6, 2018
EPS forecast (this quarter)-$0.44
Annual revenue (last year)$482.3M
Annual profit (last year)-$125.5M
Net profit margin-26.03%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Clay B. Siegall
Chief Financial Officer
Todd E. Simpson
Corporate headquarters
Bothell, Washington

Forecasts